CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.
As an established partner of federal and provincial governments, industry, and academia, CQDM deploys R&D funding programs that focus on accelerating the translation of innovation into socio-economic outcomes and health benefits for our population.
Our value proposition is articulated as follows:
- A unique business-led and purpose-driven collaborative model that brings together the private and the public sector to translate innovation into economic outcomes and health benefits
- Privileged interactions with global pharma and other private sector organizations
- A market pull approach to address the priority needs of the Canadian private sector
- A collaborative model that leverages a large pool of resources and expertise
- Financial leverage to de-risk early-stage innovation and attract private investments